| Name | Title | Contact Details | 
|---|
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs
SuperGen Inc. is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
EMD Biosciences, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Chromotrax is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioMarker Strategies is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.